These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15611807)

  • 1. Symptom resolution in patients with Mycoplasma pneumoniae pneumonia.
    Marrie TJ; Beecroft M; Herman-Gnjidic Z; Poulin-Costello M
    Can Respir J; 2004; 11(8):573-7. PubMed ID: 15611807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolution of symptoms in patients with community-acquired pneumonia treated on an ambulatory basis.
    Marrie TJ; Beecroft MD; Herman-Gnjidic Z
    J Infect; 2004 Nov; 49(4):302-9. PubMed ID: 15474628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resolution of migratory pulmonary infiltrates by moxifloxacin in a patient with dual infection of Mycoplasma pneumoniae and Bordetella pertussis.
    Kazama I; Tamada T; Nakajima T
    Infez Med; 2012 Dec; 20(4):288-92. PubMed ID: 23299070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with immune-modulators and moxifloxacin on fulminant macrolide-resistant Mycoplasma pneumoniae infection: A case report.
    Shen Y; Zhang J; Hu Y; Shen K
    Pediatr Pulmonol; 2013 May; 48(5):519-22. PubMed ID: 22949411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukocytoclastic vasculitis induced by Mycoplasma pneumoniae infection.
    Trčko K; Marko PB; Miljković J
    Acta Dermatovenerol Croat; 2012; 20(2):119-22. PubMed ID: 22726289
    [No Abstract]   [Full Text] [Related]  

  • 6. Prolonged Mycoplasma pneumoniae infection in an elderly patient with community-acquired pneumonia.
    Takahashi T; Morozumi M; Okada T; Chiba N; Asami R; Murayama SY; Ubukata K
    J Infect Chemother; 2009 Aug; 15(4):243-7. PubMed ID: 19688244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycoplasma pneumoniae community-acquired pneumonia (CAP) in the elderly: Diagnostic significance of acute thrombocytosis.
    Cunha BA; Pherez FM
    Heart Lung; 2009; 38(5):444-9. PubMed ID: 19755196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mycoplasma pneumonia of identical twin sisters with different clinical courses depending on the treatment].
    Tanaka G; Nagatomo Y; Kai Y; Matsuyama M; Kuroki M; Sasaki T; Murai K; Okayama A; Tsubouchi H
    Kansenshogaku Zasshi; 2002 Dec; 76(12):1040-4. PubMed ID: 12607352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycoplasma pneumoniae bronchiolitis mimicking asthma in an adult.
    Vasudevan VP; Suryanarayanan M; Shahzad S; Megjhani M
    Respir Care; 2012 Nov; 57(11):1974-6. PubMed ID: 22418091
    [No Abstract]   [Full Text] [Related]  

  • 10. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acute exacerbated chronic bronchitis. Antibiotics in comparison].
    MMW Fortschr Med; 2003 Oct; 145(40):57. PubMed ID: 14603610
    [No Abstract]   [Full Text] [Related]  

  • 12. Moxifloxacin punctum plug for sustained drug delivery.
    Chee SP
    J Ocul Pharmacol Ther; 2012 Aug; 28(4):340-9. PubMed ID: 22191856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coinfection with Mycoplasma pneumoniae and Chlamydophila pneumoniae in a middle-aged adult].
    Kubo T; Takigawa N; Tanimoto Y; Ichihara E; Tabata M; Miyahara N; Kanehiro A; Kiura K; Tanimoto M
    Nihon Kokyuki Gakkai Zasshi; 2007 Oct; 45(10):808-11. PubMed ID: 18018632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New indications for novel fluoroquinolones: moxifloxacin in the treatment of nosocomial infections].
    Beloborodova NV; Popov DA; Vostrikova TIu; Bachinskaia EN; Kuznetsova ST
    Antibiot Khimioter; 2009; 54(1-2):25-6, 28-30. PubMed ID: 19499714
    [No Abstract]   [Full Text] [Related]  

  • 15. Multicenter surveillance of adult atypical pneumonia in Japan: its clinical features, and efficacy and safety of clarithromycin.
    Goto H
    J Infect Chemother; 2011 Feb; 17(1):97-104. PubMed ID: 21210175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of moxifloxacin for community-acquired bacterial pneumonia based on pharmacokinetic analysis.
    Yoshida K; Okimoto N; Kishimoto M; Fukano H; Hara H; Yoneyama H; Moriya O; Kawanishi M; Kimura M; Matsushima T; Niki Y
    J Infect Chemother; 2011 Oct; 17(5):678-85. PubMed ID: 21847518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of Mycobacterium massiliense lung disease with oral antibiotics only.
    Koh WJ; Jeon K; Shin SJ
    Antimicrob Agents Chemother; 2013 Feb; 57(2):1098-100. PubMed ID: 23183432
    [No Abstract]   [Full Text] [Related]  

  • 18. [Moxifloxacin in the treatment of chronic bronchitis--clinical evaluation and assessment by patients].
    Lorenz J; Busch W; Thate-Waschke IM;
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():63-70. PubMed ID: 15700488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and bacteriological efficacy and safety of 5 and 7 day regimens of telithromycin once daily compared with a 10 day regimen of clarithromycin twice daily in patients with mild to moderate community-acquired pneumonia.
    Tellier G; Niederman MS; Nusrat R; Patel M; Lavin B
    J Antimicrob Chemother; 2004 Aug; 54(2):515-23. PubMed ID: 15269191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mycoplasma pneumonia in young children, 2-5 years of age.
    Bunnag T; Lochindarat S; Srisan P; Jetanachai P
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S124-7. PubMed ID: 19253507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.